Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

17%

3 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (6)
Early P 1 (1)
P 1 (2)
P 4 (3)

Trial Status

Completed11
Unknown3
Recruiting2
Not Yet Recruiting1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07248046Recruiting

Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)

NCT07173361Phase 1Not Yet Recruiting

Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)

NCT06928844Not ApplicableRecruiting

Role of Low Dose Injectable Progesterone in Triggering Ovulation

NCT05481684Not ApplicableUnknown

The Importance of Embryo Transfer Day Progesterone Value in Natural Cycle Frozen Embryo Transfers and the Evaluation of the Effect of Rescue Therapy on Pregnancy Outcomes in Patients With Low Progesterone Levels

NCT05742503CompletedPrimary

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

NCT05276531Not ApplicableCompletedPrimary

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

NCT03734770Not ApplicableCompletedPrimary

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support

NCT04140968Phase 4Terminated

Progesterone and Resting Energy Expenditure

NCT04769401Not ApplicableCompleted

Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle

NCT03677336Phase 4Completed

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

NCT04535973Completed

Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome

NCT03740568Not ApplicableCompleted

Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes.

NCT03340701Phase 1CompletedPrimary

Pharmacokinetics of Progesterone in Pregnancy

NCT04253470CompletedPrimary

Debate on Progesterone Elevation on the Day of Triggering

NCT04124913Phase 4Unknown

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

NCT03456570Early Phase 1Unknown

The Efficacy of Progestins in Treatment of Functional Ovarian Cyst

NCT02323347CompletedPrimary

Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer

NCT00264407CompletedPrimary

Neural Changes in the Aging Auditory System

Showing all 18 trials

Research Network

Activity Timeline